<DOC>
	<DOCNO>NCT02012582</DOCNO>
	<brief_summary>In exploratory multi-center Phase 2 study safety , tolerability , pharmacodynamics pharmacokinetics Nitric Oxide Synthase inhibitor VAS203 assess patient moderate severe traumatic brain injury . Traumatic brain injury patient ( 32 male ) receive 15 , 20 30 mg/kg VAS203 , respectively , continuous infusion three cohort ( Cohort 1 open ; Cohorts 2 3 double blind , randomise placebo-controlled ) . End Study patient Day 14 ; adverse event concomitant medication document throughout study . Objectives assess safety tolerability VAS203 , evaluate concentration metabolite VAS203 plasma microdialysate assess pharmacodynamic effect VAS203 surrogate parameter . Safety parameter include vital sign ( blood pressure heart rate , respiration rate , oxygen saturation blood gas ) , fluid balance , ECG , laboratory examination ( clinical chemistry , liver function , haematology/coagulation , urinalysis , renal parameter ) adverse event . Concentration VAS203 determine plasma microdialysate . Pharmacodynamic parameter include intracranial pressure ( ICP ) , biochemical parameter microdialysate ( nitrite/nitrate , arginine , citrulline , pyruvate , lactate , glucose ) , Partial Oxygen Pressure brain parenchyma Therapy Intensity Level ( TIL ) .</brief_summary>
	<brief_title>Phase 2 Study Assess Safety Pharmacokinetics VAS203 Patients With Traumatic Brain Injury</brief_title>
	<detailed_description>Intravenous administration study medication patient start soon possible later 12 hour trauma . Patients Group 1 receive open label study drug ( VAS203 ) . Patients Group 2 3 randomised treatment VAS203 placebo . In addition study treatment , patient receive best `` standard care '' study centre ; treatment withheld .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Written inform consent patient 's legal guardian legal representative 18 65 year age , inclusive Head trauma within last 12 hour Traumatic brain injury Glasgow Coma Score ( GCS ) ≥ 5 require ICP monitoring Catheter placement monitoring management increase ICP Microdialysis probe placement penumbra zone ipsilateral contusion focal Systolic blood pressure ≥ 100 mmHg Females childbearing potential must negative pregnancy test Penetrating head injury ( e.g . missile , stab wound ) Not expect survive 24 hour admission Concurrent , preexisting , spinal cord injury Unilateral bilateral fix dilate pupil ( &gt; 4 mm ) Cardiopulmonary resuscitation perform post injury continue bleed likely require multiple transfusion ( &gt; 4 unit red blood cell ) Coma due `` pure '' epidural hematoma ( lucid interval absence structural brain damage CT scan ) Coma suspect primarily due cause head injury ( e.g . drug overdose ) Known CT scan evidence preexist major cerebral damage Decompressive craniectomy , plan prior randomization Polytraumatic patient Injury Severity Score &gt; 25 , rhabdomyolysis Injuries ascend aorta and/or carotid artery serum creatinine value &gt; 1.5 mg/dL estimate Glomerular Filtration Rate &lt; 60 ml/min ( MDRDformula ) body mass index ( BMI ) &gt; 35 , Body weight &gt; 120 kg Any severe concomitant condition ( cancer ; hematologic , renal , hepatic , coronary disease ; major psychiatric disorder ; alcohol drug abuse ) , ascertained admission Known receive experimental drug within 4 week prior current injury Administration &gt; 100 ml contrast medium contain iodine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>